Modified recombinant allergens for safer immunotherapy.
Ferreira F, Briza P, Inführ D, Schmidt G, Wallner M, Wopfner N, Thalhamer J, Achatz G.
Ferreira F, et al. Among authors: wallner m.
Inflamm Allergy Drug Targets. 2006 Jan;5(1):5-14. doi: 10.2174/187152806775269295.
Inflamm Allergy Drug Targets. 2006.
PMID: 16613559
Review.